MAPK8 and central nervous system cancer: Although the exact mechanisms by which JNK contributes to cancer development and maintenance remain largely unknown, we have demonstrated that JNK is a key molecule in the maintenance of glioma stem cells and, most importantly, is a viable molecular target for glioma stem cell-directed therapy [9, 10].